Equity Overview
Price & Market Data
Price: $14.34
Daily Change: $0.00 / 0.00%
Range: $0 - $0
Market Cap: $972,606,272
Volume: 0
Performance Metrics
1 Week: -0.07%
1 Month: 22.67%
3 Months: 36.96%
6 Months: 50.47%
1 Year: 187.4%
YTD: 77.04%
Company Details
Employees: 65
Sector: Health technology
Industry: Biotechnology
Country: United States
Details
CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for life-threatening diseases and conditions in the United States. Its lead product candidate is DefenCath, an antimicrobial catheter lock solution to reduce the incidence of catheter-related bloodstream infections in adult patients with kidney failure. The company was formerly known as Picton Holding Company, Inc. and changed its name to CorMedix, Inc. in January 2007. CorMedix Inc. was incorporated in 2006 and is based in Berkeley Heights, New Jersey.